Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

Robert E.J. Ryder; Ralph A. DeFronzo

doi:10.1111/dme.14053

Pioglitazone: inexpensive; very effective at reducing HbA_1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

Robert E.J. Ryder, Ralph A. DeFronzo

Division of Diabetes

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	1185-1186
Number of pages	2
Journal	Diabetic Medicine
Volume	36
Issue number	9
DOIs	https://doi.org/10.1111/dme.14053
State	Published - 2019

ASJC Scopus subject areas

Endocrinology
Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1111/dme.14053

Cite this

@article{4b37175684b84ba08d081a15ee1dcf4a,

title = "Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit",

author = "Ryder, {Robert E.J.} and DeFronzo, {Ralph A.}",

year = "2019",

doi = "10.1111/dme.14053",

language = "English (US)",

volume = "36",

pages = "1185--1186",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - Pioglitazone

T2 - inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

AU - Ryder, Robert E.J.

AU - DeFronzo, Ralph A.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85068459639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068459639&partnerID=8YFLogxK

U2 - 10.1111/dme.14053

DO - 10.1111/dme.14053

M3 - Letter

C2 - 31215063

AN - SCOPUS:85068459639

SN - 0742-3071

VL - 36

SP - 1185

EP - 1186

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 9

ER -

Pioglitazone: inexpensive; very effective at reducing HbA1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Pioglitazone: inexpensive; very effective at reducing HbA_1c; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit